Dr. David Brendel answers the question: 'Substance Abuse And Depression?' — -- Question: What is the relationship between depression and substance abuse? Answer: There is a very close ...
WASHINGTON — As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic ...
People with depression have a more than doubled risk of developing epilepsy, and the mental illness also makes epilepsy more ...
Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory ...
Hi, I'm Joslin Morquecho, a licensed social worker with an MSW from Aurora University. I use evidence-based approaches like mindfulness and CBT to empower individuals in overcoming life's challenges.
Our specialty areas include working with people of color, trauma, substance use, trauma, working with the LGBTQ community, couples, depression and anxiety. The Mahogany Projek was created out love for ...
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...
A newly approved medication to treat postpartum depression will cost $15,900 per 14-day course, before insurance, when it reaches the market later this year, raising concerns among doctors and ...
The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae ...
A Sage Therapeutics drug developed to treat postpartum depression has won FDA approval, making it the first oral therapy for the disorder. But it’s a mixed regulatory outcome for the drug, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results